Literature DB >> 11327857

Solution structures and integrin binding activities of an RGD peptide with two isomers.

N Assa-Munt1, X Jia, P Laakkonen, E Ruoslahti.   

Abstract

The Arg-Gly-Asp (RGD) sequence serves as the primary integrin recognition site in extracellular matrix proteins, and peptides containing this sequence can mimic the activities of the matrix proteins. Depending on the context of the RGD sequence, an RGD-containing peptide may bind to all of the RGD-directed integrins, to a few, or to only a single one. We have previously isolated from a phage-displayed peptide library a cyclic peptide that binds avidly to the alpha(v)beta3 and alpha(v)beta5 integrins but does not bind to other closely related integrins. This peptide, ACDCRGDCFCG, exists in two natural configurations depending on internal disulfide bonding. The peptide with the 1-4; 2-3 disulfide bond arrangement accounts for most of the alpha(v) integrin binding activity, whereas the 1-3; 2-4 peptide is about 10-fold less potent. Solution structure analysis by nuclear magnetic resonance reveals an entirely different presentation of the RGD motif in the two isomers of RGD-4C. These results provide new insight into the ligand recognition specificity of integrins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327857     DOI: 10.1021/bi002101f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Integrin-targeting block copolymer probes for two-photon fluorescence bioimaging.

Authors:  Sanchita Biswas; Xuhua Wang; Alma R Morales; Hyo-Yang Ahn; Kevin D Belfield
Journal:  Biomacromolecules       Date:  2010-12-29       Impact factor: 6.988

Review 2.  Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?

Authors:  Roland Haubner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

3.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

4.  Exploring new near-infrared fluorescent disulfide-based cyclic RGD peptide analogs for potential integrin-targeted optical imaging.

Authors:  Yunpeng Ye; Baogang Xu; Gregory V Nikiforovich; Sharon Bloch; Samuel Achilefu
Journal:  Bioorg Med Chem Lett       Date:  2011-02-23       Impact factor: 2.823

5.  Synthesis and cell adhesive properties of linear and cyclic RGD functionalized polynorbornene thin films.

Authors:  Paresma R Patel; Rosemary Conrad Kiser; Ying Y Lu; Eileen Fong; Wilson C Ho; David A Tirrell; Robert H Grubbs
Journal:  Biomacromolecules       Date:  2012-07-27       Impact factor: 6.988

6.  RGD-IL-24, a novel tumor-targeted fusion cytokine: expression, purification and functional evaluation.

Authors:  Bin Xiao; Wei Li; Jun Yang; Gang Guo; Xu-Hu Mao; Quan-Ming Zou
Journal:  Mol Biotechnol       Date:  2008-10-25       Impact factor: 2.695

7.  Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.

Authors:  Mark P Borgman; Abhijit Ray; Rohit B Kolhatkar; Edward A Sausville; Angelika M Burger; Hamidreza Ghandehari
Journal:  Pharm Res       Date:  2009-02-19       Impact factor: 4.200

8.  Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin.

Authors:  Jami Mandelin; Emme C K Lin; Dana D Hu; Susan K Knowles; Kim-Anh Do; Xuemei Wang; E Helene Sage; Jeffrey W Smith; Wadih Arap; Renata Pasqualini
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

9.  Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX.

Authors:  Jort Vellinga; Martijn J W E Rabelink; Steve J Cramer; Diana J M van den Wollenberg; Hans Van der Meulen; Keith N Leppard; Frits J Fallaux; Rob C Hoeben
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Characteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligands.

Authors:  Arun Ammayappan; Kah-Whye Peng; Stephen J Russell
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.